Dimensional Fund Advisors
VYNE icon

Dimensional Fund Advisors’s VYNE Therapeutics VYNE Stock Holding History

Dimensional Fund Advisors’s Portfolio VYNE Stock Details VYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-499
Closed -$57K – 3424
2020
Q4 		$57K Sell
499
-56
-10% -$7.04K ﹤0.01% 3313
2020
Q3 		$66K Sell
555
-764
-58% -$89.1K ﹤0.01% 3290
2020
Q2 		$164K Sell
1,319
-991
-43% -$134K ﹤0.01% 3231
2020
Q1 		$446K Buy
2,310
+971
+73% +$305K ﹤0.01% 3076
2019
Q4 		$447K Buy
1,339
+645
+93% +$215K ﹤0.01% 3150
2019
Q3 		$224K Buy
694
+186
+37% +$60K ﹤0.01% 3266
2019
Q2 		$219K Buy
+508
New +$251K ﹤0.01% 3306

Other funds holding VYNE

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Dimensional Fund Advisors's VYNE Position: Q1 2021 in Review

Dimensional Fund Advisors sold out of VYNE Therapeutics (VYNE) in Q1 2021, closing a stake of 499 shares — an estimated $57K sold.

Dimensional Fund Advisors first reported a position in VYNE in Q2 2019 and held it in 7 quarters. The position peaked at $447K in Q4 2019. 89 funds tracked by Wall St. Rank hold VYNE as of Q1 2021.

  • Dimensional Fund Advisors reported no remaining VYNE Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 499 VYNE Therapeutics shares in Q1 2021, an estimated $57K.
  • Dimensional Fund Advisors first reported a position in VYNE Therapeutics in Q2 2019 and held it in 7 quarters.
  • Dimensional Fund Advisors's VYNE Therapeutics position peaked at $447K in Q4 2019.
  • 89 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q1 2021.

Based on Dimensional Fund Advisors's 13F filing for Q1 2021, filed 14 May 2021.